Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 77.99K 71.57K 65.1K 122K 8.27M 124K 855K 345K 4.36M 328K 321K 13.79M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 219M 201M 183M 343M 23.26B 350M 2.4B 969M 12.28B 922M 903M 38.78B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.12%+10.41%+57.53%+143.38% 1,263B
-1.09%+1.45%+45.04%+79.82% 658B
-2.07%+0.59%+36.08%+101.34% 521B
-1.54%+0.18%+53.06%+66.79% 391B
-0.34%+5.87%+80.46%+44.74% 369B
-1.69%+3.17%+32.18%+55.35% 307B
-0.72%+7.83%+12.10%+33.76% 290B
+0.32%+4.95%+57.50%+75.05% 252B
+0.28%+7.72%+40.06%+110.45% 212B
Average -0.71%+5.31%+46.00%+78.96% 426.19B
Weighted average by Cap. -0.77%+6.60%+48.77%+93.39%

Financials

2016 2017
Net sales 54.27M 48.45M 44.46M 40.45M 75.83M 5.14B 77.34M 531M 214M 2.71B 204M 199M 8.57B 106M 94.59M 86.8M 78.96M 148M 10.03B 151M 1.04B 418M 5.29B 398M 389M 16.72B
Net income -103M -91.94M -84.37M -76.75M -144M -9.75B -147M -1.01B -406M -5.15B -386M -378M -16.25B -125M -112M -103M -93.31M -175M -11.85B -178M -1.23B -494M -6.26B -470M -460M -19.76B
Net Debt 209M 187M 172M 156M 293M 19.83B 299M 2.05B 826M 10.47B 786M 770M 33.06B 246M 219M 201M 183M 343M 23.26B 350M 2.4B 969M 12.27B 922M 902M 38.77B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock